Original Article
You have full text access to this OnlineOpen article
Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura
Article first published online: 19 NOV 2000
DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1740::AID-CNCR14>3.0.CO;2-9
Copyright © 1999 American Cancer Society
Additional Information
How to Cite
Kasseyet, S., Astoul, P. and Boutin, C. (1999), Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura. Cancer, 85: 1740–1749. doi: 10.1002/(SICI)1097-0142(19990415)85:8<1740::AID-CNCR14>3.0.CO;2-9
Publication History
- Issue published online: 19 NOV 2000
- Article first published online: 19 NOV 2000
- Manuscript Accepted: 4 DEC 1998
- Manuscript Revised: 9 NOV 1998
- Manuscript Received: 8 JUN 1998
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , 4.2. Chimiothérapie du mésothéliome pleural malin, Revue des Maladies Respiratoires, 2006, 23, 4, 57
- 2, , , , , , , , Intrapleural Hypotonic Cisplatin Treatment for Malignant Pleural Mesothelioma: In Vitro Experiments and Clinical Application, Surgery Today, 2006, 36, 2, 135
- 3, , , , , The Use of Chemotherapy in Patients with Advanced Malignant Pleural Mesothelioma: A Systematic Review and Practice Guideline, Journal of Thoracic Oncology, 2006, 1, 6, 591
- 4, , , , , , , , , , , , , , , Treatment With Oral Etoposide for Childhood Recurrent Ependymomas, Journal of Pediatric Hematology/Oncology, 2005, 27, 9, 486
- 5, , Integration of Multimodality Approaches in the Management of Malignant Pleural Mesothelioma, Clinical Lung Cancer, 2004, 5, 5, 290
- 6
- 7
- 8, , , , , , , , Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis, Lung Cancer, 2002, 38, 2, 111
- 9, Chemotherapy for malignant mesothelioma: From doxorubicin to vinorelbine, Seminars in Oncology, 2002, 29, 1, 62
- 10, , , The emerging role of antifolates in the treatment of malignant pleural mesothelioma, Seminars in Oncology, 2002, 29, 1, 77
- 11, , , , , , , , , Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma, The Journal of Pathology, 2001, 193, 4Direct Link:
- 12

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)